Skip to main content
Sign In
This is archived ASPR content.
U.S. Department of Health & Human Services
Toggle navigation
About US
Overview
About Us
Join and Connect
Stay Up-To-Date
Strategic Plan | 2022-2026
ASPR Careers
Newsroom
Leadership Biographies
Boards and Committees
Blog
Organization Chart
Partnering with ASPR
Budget and Funding
Response Operations
Overview
Join. Train. Respond.
Response Resources
Law and Strategy
National Disaster Medical System
Cybersecurity
Public Health Emergency Declarations
Medical Reserve Corps
At-Risk Individuals
Section 1135 Waivers
ESAR-VHP
Disaster Behavioral Health
National Response Framework and Emergency Support Function 8
Emergency Prescription Assistance Program
Legal Authorities, Policies, and Strategies
National Emergency Telemedicine Network
ASPR TRACIE
Health Care Readiness
Overview
Health Care Readiness
Programs and Activities
Resources and Funding
Related Programs
Stories from the Field
Hospital Preparedness Program
Health Care Readiness Funding
Critical Infrastructure Protection
Health Care Readiness Near You
Regional Disaster Health Response System
COVID-19 Health Care Preparedness and Response
Health and Social Services Recovery
National Special Pathogen System
Health Care Readiness Program Webinars
Workforce Capacity and Capability
Performance Measures, Guidance, and Reports
Medical Countermeasures & Biodefense
Overview
Medical Countermeasures
Biodefense
Project NextGen
Industrial Base Expansion
BARDA
S3: Science, Safety, and Security
Doing Business with BARDA
Strategic Planning and Committees
Strategic National Stockpile
Legal Authorities, Policies, and Strategies
Partnering
Overview
Partnership Opportunities
Professional Resources
Join Us
Medical Countermeasures TechWatch
ASPR TRACIE
National Disaster Medical System
EZ-BAA: BARDA DRIVe Easy Broad Agency Announcement
National Emerging Special Pathogens Training and Education Center
Medical Reserve Corps
BARDA Broad Agency Announcement
Critical Infrastructure Protection
ESAR-VHP
IBx Connect
Boards and Committees
Blue Knight
NACCD - Children and Disasters
CARB-X
NACIDD - Disabilities and Disasters
BARDA Ventures
NACSD - Seniors and Disasters
BARDA DRIVe Accelerator Network
NBSB – Biodefense
Project BioShield
Find Us On SAM
ASPR Grant Opportunities
Tools
Overview
Technical Assistance and Information Management
GIS-Based Tools
ASPR TRACIE
HHS emPOWER Program
Regional Emergency Coordinators
GeoHEALTH
ASPR Ready
COVID-19 Test to Treat Locator
Training
COVID-19 Therapeutics Locator
HHS emPOWER Program Web-Based Training
Threat-specific Tools
Strategic National Stockpile Course Listing
CHEMM: Chemical Hazards Emergency Medical Management
Addressing the Needs of Older Adults in Disasters Web Based Training
REMM: Radiation Emergency Medical Management
Access and Functional Needs Web-Based Training
Risk Assessment Tools
Risk Identification and Site Criticality (RISC 2.0)
COVID-19
ASPR COVID-19 Response
For Health Care Professionals
For Patients
Test to Treat
NAVIGATION
ASPR's Response to Monkeypox
News and Announcements
ASPR’s Mpox News and Announcements
December 2, 2022:
Statement From HHS Secretary Becerra on Mpox
November 28, 2022:
Biden-Harris Administration Supports the World Health Organization Renaming of Monkeypox to mpox
October 3, 2022:
HHS Amends PREP Act Declaration Increasing Workforce Authorized to Administer Monkeypox Vaccines
September 6, 2022:
HHS Awards $20 Million Contract to AmerisourceBergen to Expand, Quicken Distribution of Vaccines and Treatments for Monkeypox
August 29, 2022:
HHS Funds U.S.-Based Production of Smallpox and Monkeypox Vaccine
August 22, 2022:
HHS Facilitates Agreement to Accelerate Delivery of Additional Smallpox and Monkeypox Vaccines Using New U.S. Production Line
August 9, 2022:
FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply
August 9, 2022:
HHS Secretary Becerra Issues 564 Determination, Paving Way for Emergency Use Authorization of Monkeypox Vaccines
August 4, 2022:
Biden-Harris Administration Bolsters Monkeypox Response; HHS Secretary Becerra Declares Public Health Emergency
July 28, 2022:
HHS expands availability of monkeypox vaccine to more than 1.1 Million Doses
July 28, 2022:
HHS allocates and distribrutes JYNNEOS monkeypox vaccine to jurisdictions nationwide
July 15, 2022:
HHS orders additional vaccine, increases testing capacity to respond to monkeypox outbreak
July 7, 2022:
Biden-Harris Administration to make an additional 144,000 doses of JYNNEOS vaccine available to states and jurisdictions for monkeypox response
July 1, 2022:
Biden-Harris Administration Announces Additional Deliveries of Vaccine as Part of Nationwide Vaccine Strategy for Preventing Monkeypox
July 1, 2022:
HHS Orders 2.5 Million More Doses of JYNNEOS Vaccine For Monkeypox Preparedness
June 28, 2022:
HHS Announces Enhanced Strategy to Vaccinate and Protect At-Risk Individuals from the Current Monkeypox Outbreak
June 6, 2022:
Responding to the Monkeypox Outbreak with Vaccines and Treatments
May 24, 2022:
Prepared to Respond: COVID, Monkeypox, and Infant Formula
ASPR's Response to the Monkeypox Outbreak
News and Announcements
ASPR’s Monkeypox News and Announcements
Vaccines
JYNNEOS Vaccine Distribution by Jurisdiction
ASPR/CDC Monkeypox Vaccination Operational Planning Guide - HHS Monkeypox Vaccination Program
National Monkeypox Vaccine Strategy Interim Reporting Guidance
Therapeutic
TPOXX Thresholds by Jurisdiction
TPOXX (Tecovirimat) Operational Planning Guide
Overview of SNS Products
Overview
This is archived ASPR content.